These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6830958)

  • 61. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 63. [The pharmacokinetic aspects of the clinical action of gidazepam].
    Zherdev VP; Neznamov GG; Kolyvanov GB; Litvin AA; Otabekova SG
    Eksp Klin Farmakol; 1993; 56(3):50-2. PubMed ID: 8106055
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Combination of phenazepam and diazepam with analgesics].
    Aleksandrova GM; El'tsova ZI; Efremova GN; Zorian EV; Milogradova GP
    Farmakol Toksikol; 1981; 44(2):147-51. PubMed ID: 6895069
    [No Abstract]   [Full Text] [Related]  

  • 65. [New pharmacodynamic effects of gidazepam and befol in patients with cardiac arrhythmias].
    Skibitskiĭ VV; Kanorskiĭ SG
    Eksp Klin Farmakol; 1993; 56(5):23-7. PubMed ID: 7906171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
    Patkina NA; Evartau EE
    Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effect of the tranquilizer gidazepam on the behavioral reactions of rats in the first weeks after resuscitation].
    Mutuskina EA; Garibova TL; Zarzhetskiĭ IuV; Maula M; Voronina TA; Gurvich AM
    Patol Fiziol Eksp Ter; 1994; (3):10-2. PubMed ID: 7824332
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of emotional stress on the frequency of chromosome aberrations in the bone marrow cells of mice].
    Seredenin SB; Durnev AD; Vedernikov AA
    Biull Eksp Biol Med; 1980 Jul; 89(7):91-2. PubMed ID: 7190853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Behavioral and electrophysiologic analysis of the anxiolytic effect of astragalus mongolian].
    Molodavkin GM; Aldarmaa Zh; Voronina TA; Davgatsérén B
    Biull Eksp Biol Med; 1998 Apr; 125(4):407-9. PubMed ID: 9631722
    [No Abstract]   [Full Text] [Related]  

  • 70. [An experimental model of benzodiazepine intoxication].
    Georgianova EK; Lychakov AV; Malov AM; Nikolaev AI; Petrov AN; Savateeva TN; Tomilin NV; Shevchuk MK; Shestova GV
    Eksp Klin Farmakol; 1997; 60(5):61-4. PubMed ID: 9483410
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The effect of fenazepam on the humoral immune response in secondary immunodeficiency].
    Zabrodskiĭ PF
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):65-7. PubMed ID: 1362313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical pharmacokinetics of mebikar. Computation of individual dosage regimens].
    Treskov VG; Berliand AS; Serov NV; Sidorov AA; Knizhnik AZ
    Farmakol Toksikol; 1985; 48(1):46-8. PubMed ID: 3979535
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
    Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA
    Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
    [No Abstract]   [Full Text] [Related]  

  • 74. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
    Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
    Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Antioxidative activity of drugs used in anticonvulsive therapy].
    Nikushkin EV; Bordiukov MM
    Biull Eksp Biol Med; 1993 Mar; 115(3):254-6. PubMed ID: 8054610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Nature of the relation between the anticonvulsant action of phenazepam and its concentration in mouse brain].
    Zin'kovskiĭ VG; Golovenko NIa; Bogatskiĭ AV
    Biull Eksp Biol Med; 1981; 91(1):40-2. PubMed ID: 7214004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical pharmacokinetics of mebikar].
    Serov NV; Treskov VG; Berliand AS; Knizhnik AZ; Lapin KV
    Farmakol Toksikol; 1984; 47(3):94-7. PubMed ID: 6734814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The neural mechanism underlying the female advantage in identifying negative emotions: an event-related potential study.
    Li H; Yuan J; Lin C
    Neuroimage; 2008 May; 40(4):1921-9. PubMed ID: 18343686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of nitrous oxide on reaction time and cerebral evoked potential.
    Jarvis MJ; Lader MH
    Br J Pharmacol; 1970 May; 39(1):254P-255P. PubMed ID: 5420142
    [No Abstract]   [Full Text] [Related]  

  • 80. Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.
    Rynearson RR; Wilson MR; Bickford RG
    Mayo Clin Proc; 1968 Mar; 43(3):191-204. PubMed ID: 4384806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.